C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton

Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
12/2004
12/28/2004	US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt
12/28/2004	US6835751 Bicyclic amino acids as pharmaceutical agents
12/23/2004	WO2004110981A1 A process for the preparation of gabapentin form-ii
12/23/2004	WO2004110374A2 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors
12/23/2004	WO2004110364A2 Thiotungstate analogues and uses thereof
12/23/2004	WO2004110342A2 Novel polymorph of gabapentin and its conversion to gabapentin form-ii
12/23/2004	WO2004110339A2 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
12/23/2004	US20040260120 dehydrogenation of alcohols in the presence of doped hydrogenation catalysts, to form carboxylic acids and salts
12/23/2004	US20040258620 In vivo stability, biocompatibility, organ specificity; low dosage, rapid excretion; nuclear magnetic resonance diagnostic imaging, radiotherapy
12/23/2004	CA2529486A1 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
12/23/2004	CA2527236A1 Thiotungstate analogues and uses thereof
12/22/2004	EP1487763A2 Use of microfabricated devices for radiosynthesis
12/22/2004	EP1309653A4 Polymeric methine ultraviolet absorbers
12/22/2004	EP1080066A4 Bioreductive cytotoxic agents
12/22/2004	EP1044961B1 Iron alkali salt of s,s-ethylenediamine-n,n'-disuccinic acid and process for producing the same
12/22/2004	CN1556785A Interfacial method of preparing ester-substituted diaryl carbonates
12/22/2004	CN1181055C Alanine class compound, its preparing method and use
12/22/2004	CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/22/2004	CN1181046C Prepn process of chiral compound L-homophenproobamate and its salt
12/22/2004	CN1181045C Process for producing highly pure tetrasodium salt of ethylenediaminetetracetic acid
12/21/2004	US6833471 Contacting beta-ketodiester having ketone and two esters with a ketoreductase under conditions permitting reduction of ketone to alcohol, regioselectively hydrolyzing one of ester groups to acid, converting acid or ester to amine
12/21/2004	US6833382 Streptogramins and method for preparing same by mutasynthesis
12/21/2004	CA2322989C Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents
12/21/2004	CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/21/2004	CA2193911C Ruminant feed additive composition containing novel phosphoric acid-amino acid composite salt and water-soluble substance of high molecular weight
12/21/2004	CA2134674C Gaba and l-glutamic acid analogs for antiseizure treatment
12/16/2004	WO2004093780A3 Process for the preparation of gabapentin form-ii
12/16/2004	WO2004093779A3 Process for the preparation of gabapentin form-ii
12/16/2004	WO2004082592A3 Metal amino acid chelates having nutritionally relevant anion radical (s)
12/16/2004	WO2004066929A3 Cycloalkyl containing anilide ligands for the thyroid receptor
12/16/2004	WO2004052939A3 Ligands for metals and improved metal-catalyzed processes based thereon
12/16/2004	US20040254225 Modulation of opioid receptor by binding
12/15/2004	EP1485079A2 Small molecule entry inhibitors
12/15/2004	EP1368303B1 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/15/2004	CN1555228A Enhancing solubility of iron amino acid chelates and iron proteinates
12/15/2004	CN1554325A Use of of aminosubstituted hydroxybenzophenones as photostable uv-filter in cosmetic and pharmaceutical preparations
12/15/2004	CN1179941C Process for extracting 4-hydroxy-isoluecine and by-products including feungreek gum from seed of feungreek
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004	US6831102 For treating or delaying progression or onset of obesity, hypercholesterolemia, atherosclerosis, depression, osteoporosis, hypothyroidism, non-toxic goiter, reduced bone mass, density or growth, eating disorders, cardiac arrhythmia
12/14/2004	CA2195841C Process and intermediates for (s)-.alpha.-amino-1-carboxycyclopentaneacetic acid
12/14/2004	CA2146322C Oleaginous compositions
12/09/2004	WO2004106281A1 Crystalline gabapentin
12/09/2004	WO2004039314A3 Process for synthesizing l-y-methylene glutamic acid and analogs
12/09/2004	US20040249205 Process for producing hydroxyamino acid derivative
12/09/2004	US20040249187 Method for producing chiral amino acid derivatives
12/09/2004	US20040249115 Polymerizing L-aspartic acid in the presence of an end capping initiator to form a polysuccinimide; and hydrolyzing the polysuccinimide to form the poly(succinimide-aspartate) copolymer
12/09/2004	US20040249114 Polymerizing a dicarboxylic amino acid in the presence of an end capping initiator to form the polymeric material
12/09/2004	US20040248963 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders
12/09/2004	US20040248815 Substituted amino acids as erythropoietin mimetics
12/09/2004	US20040248814 does not require the problematic use of protecting groups
12/09/2004	US20040248776 Intermediates and methods for making heptapeptide oxytocin analogues
12/09/2004	US20040247621 Combination therapy using a synergistic mixture of mechlorethamine, nitrogen mustard N-oxide, melphalan, uramustin, ifosfamide, chlorambucil, or cyclophosphamide and an anti-interleukin-6 receptor antibody; anticarcinogenic agents
12/08/2004	EP1484315A1 Process for production of optically active beta-phenylalanine
12/08/2004	EP1484314A1 Process for production of optically active beta-phenylalanine derivatives
12/08/2004	EP1484313A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
12/08/2004	EP1484301A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
12/08/2004	EP1483256A2 Process for making chiral 1,4-disubstituted piperazines
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1483232A1 Salts of nateglinide
12/08/2004	EP1483228A1 Nk1 antagonists
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	CN1553898A Method for producing 4-haloalkylnicotinic acid esters
12/08/2004	CN1552694A Preparation of D-(-)-1-benzene amino acetic acid
12/08/2004	CN1552693A Benzoylcyclohexanone amine compounds with herbicidal activity
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828450 Triptycene analogs
12/02/2004	WO2004103074A1 Copper salts of organic acids and use thereof as fungicides
12/02/2004	US20040242921 Resolution of racemic mixtures using an amine
12/02/2004	US20040242916 Process for preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
12/02/2004	US20040242891 Production of keto acids
12/02/2004	US20040242889 Hydrogenation of (acylamino)acrylate using ruthenium complex hydrogenation catalyst
12/02/2004	US20040242684 Method and compositions for inhibiting cell proliferative disorders
12/02/2004	US20040242652 Beta benzyloxyaspartate derivatives with amino group on benzene ring
12/02/2004	US20040242553 Drugs to improve synaptic transmission
12/02/2004	US20040238786 neutralizing an aqueous solution of an N,N-dialkylglycine alkali metal salt with a mineral acid; condensing the obtained solution by removal of water; and solid-liquid separation the deposited alkali metal-mineral acid salt from the resulting slurry
12/02/2004	US20040237837 Benzophenone derivative linked to hydrophylic moiety; concurrently imparts wettability and long term storage stability
12/02/2004	US20040237836 Benzophenone compound and ink composition including the same
12/02/2004	CA2525130A1 Improved cytotoxic agents comprising new maytansinoids
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1481964A1 Stable salts of novel derivatives of 3,3-diphenylpropylamines
12/01/2004	EP1480998A1 Intermediates and methods for making heptapeptide oxytocin analogues
12/01/2004	CN1551866A Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177809C Novel polyamino acid derivative
12/01/2004	CN1177808C Solid compositions suitable for oral administration composing L-carnitine and alkanoyl-L-carnitine mangesium tartrate
12/01/2004	CN1177807C Stable, nno-hygroscopic salts of L(-) carnitine and alkanoyl L(-) carnitinges, process for their preparation and solid, orally administrable compositions containing such salts
12/01/2004	CN1177805C Method for reducnig 2-dimethylamio-2-phenylpropion-acid ethyl ester content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1- carboxylic acid ethy ester
11/2004
11/30/2004	US6825365 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6825211 Bicyclic metabotropic glutamate receptor ligands
11/30/2004	US6824760 Imaging agents, precursors thereof and methods of manufacture
11/30/2004	CA2305307C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
11/25/2004	WO2004101489A1 Process for the preparation of gabapentin
11/25/2004	WO2004074255A3 Method for producing an optically active tetrahydroquinoline
11/25/2004	WO2004071416B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/25/2004	WO2003101945A8 Ligands that are inhibitors of the rar receptors
11/25/2004	US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235757 Anticarcinogenic and antimetastasis agents; leukemia or Hodgkin's disease.

1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 215